Acella's $46.5M Drug Recall Settlement Gets Initial Signoff
By Peter McGuire · February 7, 2024, 6:41 PM EST
A Georgia federal judge on Wednesday gave preliminary approval of a nearly $46.5 million settlement from Acella Pharmaceuticals LLC to end a class action alleging the company sold worthless thyroid medication...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login